indications for semaglutide Impact of Fibrotic Metabolic Dysfunction–Associated Steatohepatitis as a New Indication on Eligibility in the US Adult Population Who Qualifies for Semaglutide GLP-1

Once-weekly formulations of semaglutide (Wegovy) and daily liraglutide (Saxenda) are FDA-approved for weight loss in patients who are overweight or obese while other existing formulations are approved solely for patients with type 2 diabetes, although it is likely that broader indications for weight loss (regardless of glycemic status) are forthcoming

The adventitial adipose tissue was removed and the aorta was dissected longitudinally

It is noteworthy that two studies did not identify an effect of dietary glycine supplementation on the growth performance of juvenile rainbow trout [53] or Beluga sturgeon [54]

My concern is that select aspects of this kind of information will be used by some to further discriminate against and limit opportunities for women in the workforce